iPACES-PD: iPACES v3 MCI NIA Protocol Copied for iPACES v4 PD NINDS

Sponsor
iPACES LLC (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT05810454
Collaborator
Pacific Brain Health Center (Other), 1st Playable Productions (Other), Adirondack Neuropsychological Associates (Other), Albany Medical College (Other), Center for Balance, Mobility & Wellness at Gordon College (Other)
120
1
2
36
3.3

Study Details

Study Description

Brief Summary

The primary purpose of this study is to attempt to replicate and extend promising pilot findings regarding the cognitive benefits of in-home neuro-exergaming with iPACES (interactive Physical and Cognitive Exercise System v3) for persons with mild cognitive impairment (MCI), to evaluate effects for persons with Parkinson's Disease (PD). Participants will include persons with PD, and potentially, also their co-residing partner, who will exercise at home or accessible location, 3-5 times per week for at least 6 months, with follow-up one month after the main intervention. All participation is "remote" (completed at home, or location of choice), utilizing either one's own equipment ("bring-your-own-devices" BYODs: pedaler, phone/tablet, smart-watch) or some equipment which may be supplied by the grant-funded study and shipped directly to the home; all study measures are completed remotely (e.g., via phone app, website, biometric device, videoconference, email, snail mail, etc.).

Condition or Disease Intervention/Treatment Phase
  • Device: iPACES (interactive Physical and Cognitive Exercise System)
  • Device: PACE (Physical and Cognitive Exercise)
N/A

Detailed Description

A specific aim is to evaluate the effects of iPACES for persons with Parkinson's Disease, while also examining the potentially unique contribution of combining mental and physical exercise in an interactive way: "pedal-to-play" (iPACES), as compared with non-interactive, but simultaneous: "pedal-while-play" (PACE).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
participants are randomly assigned to either iPACES ("pedal-to-play") or PACE ("pedal-while-play") exergaming interventions to be completed 3-5x/wk for 3 months, then PACE crosses over to iPACES for 3 months, and all followed a final monthparticipants are randomly assigned to either iPACES ("pedal-to-play") or PACE ("pedal-while-play") exergaming interventions to be completed 3-5x/wk for 3 months, then PACE crosses over to iPACES for 3 months, and all followed a final month
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Neuro-exergaming for the Prevention and Remediation of Decline Due to Parkinson's Disease: Clinical Trial of the Interactive Physical and Cognitive Exercise System (iPACES-PD)
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Aug 1, 2025
Anticipated Study Completion Date :
Aug 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: iPACES (interactive Physical and Cognitive Exercise System)

iPACES (interactive Physical and Cognitive Exercise System) involves a "pedal-to-play" neuro-exergame in which physical and mental exercise are combined in an interactive way. In this condition a person will pedal to control forward motion in a tablet-based game, such as when pedaling along a virtual path and steering to different assigned errand locations.

Device: iPACES (interactive Physical and Cognitive Exercise System)
iPACES involves a "pedal-to-play" neuro-exergame in which physical and mental exercise are combined in an interactive way. In this condition a person will pedal to control forward motion in a tablet-based game, such as when pedaling along a virtual path and steering to different assigned errand locations.
Other Names:
  • neuro-exergame
  • Active Comparator: PACE (physical and cognitive exercise)

    PACE (Physical and Cognitive Exercise) involves a "pedal-while-play" experience in which physical and mental exercise are combined in a simultaneous, but not fully interactive way. In this condition a person will pedal while also separately steering in a tablet-based game, such as when pedaling while automatically progressing along a virtual path to different assigned errand locations.

    Device: PACE (Physical and Cognitive Exercise)
    PACE involves a "pedal-while-play" experience in which physical and mental exercise are combined in a simultaneous, but not fully interactive way. In this condition a person will pedal while also separately steering in a tablet-based game, such as when pedaling while automatically progressing along a virtual path to different assigned errand locations.

    Outcome Measures

    Primary Outcome Measures

    1. executive function [change from baseline to 3 months]

      cognitive function composite score from neuropsychological tests (e.g., Stroop); higher scores on the standardized composite would be centered around zero, and higher scores would indicate better performance

    2. everyday function [change from baseline to 3 months]

      subjective cognitive function in everyday living (e.g., Ecological Validity Scale); higher scores would indicate better outcomes

    Secondary Outcome Measures

    1. biomarker [change from baseline to 3 months]

      biomarker (dried blood spot samples; DBSS) linking exercise to cognitive function (e.g., planned analyses include: BDNF/Brain Derived Neurotrophic Factor and IGF-1/Insulin-like Growth Factor)

    2. visuospatial function [change from baseline to 3 months]

      cognitive function composite score from neuropsychological tests (e.g., Rey-Osterrieth Complex Figure/ReyO); higher scores would indicate better performance

    3. PD-ADLs [change from baseline to 3 months]

      Parkinson's Disease Activities of Daily Living (from the Unified Parkinson's Disease Rating Scale; UPDRS); lower scores would indicate better outcomes

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    50 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. 50 years of age or older

    2. meets criteria for MCI (per site staff/MD/neuropsychologist and confirmed by study-administered Montreal Cognitive Assessment; MoCA; score = between 16-26, non-inclusive; Milani, 2018)

    3. available for participation for one year (tablet surveys, videoconference evaluations)

    4. willing and able to exercise 3-5 times per week for at least 6 months 6. can pedal an under-table elliptical 7. can read off of a small tablet screen 8. proficient in English (speaking and reading for completion of interview, surveys, game); Spanish language option anticipated soon 9. can participate in testing and read and operate tablet touch screen (adequate hearing, vision, speech) 10. written approval from primary care physician and cardiologist (if applicable) to participate in exercise for this study 11. can provide informed consent

    Exclusion Criteria:
    1. already exercising at recommended levels (45 min of moderate intensity aerobic exercise 5-7x/wk)

    2. significant history of cardiovascular problems

    3. significant history of stroke

    4. significant history of memory problems (e.g., dementia/Alzheimer's)

    5. significant history of other neurological condition (e.g., seizures, etc.)

    6. significant uncontrolled tremor such that would interfere with touch-screen use required throughout the study (surveys, game-play, etc.)

    7. not prone to cybersickness (e.g., "car sickness" or problems with "screen time")

    8. cannot provide informed consent (i.e., when phone screened with the Impaired Decision Making Capacity screen)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 remote trial conducted in-home or nearby, across the USA; via iPACES app/video-conference/mail Clifton Park New York United States 12065

    Sponsors and Collaborators

    • iPACES LLC
    • Pacific Brain Health Center
    • 1st Playable Productions
    • Adirondack Neuropsychological Associates
    • Albany Medical College
    • Center for Balance, Mobility & Wellness at Gordon College

    Investigators

    • Principal Investigator: Bob Gillen, PhD, iPACES LLC
    • Principal Investigator: Cay Anderson-Hanley, PhD, iPACES LLC

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    iPACES LLC
    ClinicalTrials.gov Identifier:
    NCT05810454
    Other Study ID Numbers:
    • 2021 iPACES v3 MCI NIA copy PD
    First Posted:
    Apr 12, 2023
    Last Update Posted:
    Apr 12, 2023
    Last Verified:
    Apr 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by iPACES LLC
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 12, 2023